Application status and research progress in perioperative chemoradiotherapy for T 3 rectal cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
; (6): 1010-1014, 2023.
Artículo
en Chino
| WPRIM (Pacífico Occidental)
| ID: wpr-1027448
Biblioteca responsable:
WPRO
ABSTRACT
T 3 rectal cancer patients are a heterogeneous group of populations. T 3 stage patients with good prognosis are similar to their T 2 stage counterparts, and T 3 stage patients with poor prognosis are similar to T 4 stage counterparts. Although small sample clinical trials, meta-analyses and retrospective analyses have been conducted, clinical guidelines are not completely consistent with the definition of risk factors and treatment recommendations for this group of populations. At present, the treatment strategy for T 3 rectal cancer is still controversial, especially the application of perioperative radiotherapy. In this article, current application status and research progress in perioperative chemoradiotherapy for T 3 rectal cancer were reviewed.
Texto completo:
Disponible
Base de datos:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Radiation Oncology
Año:
2023
Tipo del documento:
Artículo